BioSpace News Archive

OSSIO Announces U.S. Launch and First Commercial Use of the Bio-Integrative OSSIO fiber ® Compression Screw Portfolio Company Secures $20 Million in Financing to Accelerate Product Development & Advance Commercialization

Tauriga Sciences, Inc., a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums, additional product offerings, as well as an ongoing Pharmaceutical Development initiative, announced that on March 17, 2021, the Company filed an International Patent Application under the Patent Cooperation Treaty.

Aeglea receives $21.5 million upfront with up to approximately $130 million in milestone payments and royalties in the mid-twenties Immedica obtains exclusive commercialization rights in Europe and several Middle Eastern countries

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that an IND (Investigational New Drug) application for its ovarian cancer CAR-T (Chimeric Antigen Receptor T-cell) therapy has been filed with the U.S. Food and Drug Administration